{"id":"https://openalex.org/W2614959352","doi":"https://doi.org/10.1182/blood.v128.22.464.464","title":"Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)","display_name":"Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2614959352","doi":"https://doi.org/10.1182/blood.v128.22.464.464","mag":"2614959352"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.464.464","doi":"https://doi.org/10.1182/blood.v128.22.464.464","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.464.464","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100637086","display_name":"Xiaofan Li","orcid":"https://orcid.org/0000-0002-4783-7372","observed_orcids":["https://orcid.org/0000-0002-4783-7372","https://orcid.org/0000-0003-3658-6480"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaofan Li","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022112792","display_name":"Cristina L. Abrahams","orcid":"https://orcid.org/0000-0003-4744-2343","observed_orcids":["https://orcid.org/0000-0003-4744-2343"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cristina Abrahams","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003346545","display_name":"Millicent G. Embry","orcid":"https://orcid.org/0009-0007-2143-6179","observed_orcids":["https://orcid.org/0009-0007-2143-6179"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Millicent Embry","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104018917","display_name":"Abigail Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Abigail Yu","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037805629","display_name":"Jason A. Kahana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jason Kahana","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103044490","display_name":"Michael T. Brown","orcid":"https://orcid.org/0000-0003-3937-1477","observed_orcids":["https://orcid.org/0000-0003-3937-1477"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Michael Brown","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033160069","display_name":"Rama Krishna Narla","orcid":"https://orcid.org/0000-0001-5181-3376","observed_orcids":["https://orcid.org/0000-0001-5181-3376"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rama Krishna Narla","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103593186","display_name":"Leo A. Barnes","orcid":"https://orcid.org/0009-0005-3603-3941","observed_orcids":["https://orcid.org/0009-0005-3603-3941"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Leo Barnes","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011094534","display_name":"Eric B. Schwartz","orcid":"https://orcid.org/0000-0001-6722-180X","observed_orcids":["https://orcid.org/0000-0001-6722-180X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Eric Schwartz","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110866577","display_name":"John F. Boylan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Boylan","raw_affiliation_strings":["Celgene, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066984672","display_name":"James F. Zawada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James Zawada","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016532798","display_name":"Heather T. Stephenson","orcid":"https://orcid.org/0000-0001-9217-6369","observed_orcids":["https://orcid.org/0000-0001-9217-6369"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heather Stephenson","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015400481","display_name":"Maureen Bruhns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maureen Bruhns","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002590050","display_name":"Stuart Bussell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stuart Bussell","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alexander Steiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexander Steiner","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064566753","display_name":"Adam A. Galan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Adam Galan","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014394545","display_name":"Toni B. Kline","orcid":"https://orcid.org/0000-0001-5496-1366","observed_orcids":["https://orcid.org/0000-0001-5496-1366"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Toni Kline","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027822073","display_name":"Alice Yen-Wen Yam","orcid":"https://orcid.org/0000-0001-5650-6973","observed_orcids":["https://orcid.org/0000-0001-5650-6973"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alice Yam","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045125816","display_name":"Ryan Stafford","orcid":"https://orcid.org/0000-0002-3584-9966","observed_orcids":["https://orcid.org/0000-0002-3584-9966"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ryan Stafford","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078931237","display_name":"Heidi M. Hoffmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Heidi Hoffmann","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012211904","display_name":"Shannon L. Matheny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shannon Matheny","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073561330","display_name":"Venita I. DeAlmeida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Venita DeAlmeida","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068191293","display_name":"Nicki J. Vasquez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicki Vasquez","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070704216","display_name":"Henry G. Heinsohn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Henry Heinsohn","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087863988","display_name":"Aaron K. Sato","orcid":"https://orcid.org/0000-0003-1922-9780","observed_orcids":["https://orcid.org/0000-0003-1922-9780"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aaron Sato","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105420874","display_name":"Arturo Molina","orcid":"https://orcid.org/0009-0008-0161-5775","observed_orcids":["https://orcid.org/0009-0008-0161-5775"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arturo Molina","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073536299","display_name":"Trevor J. Hallam","orcid":"https://orcid.org/0000-0002-4621-3373","observed_orcids":["https://orcid.org/0000-0002-4621-3373"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Trevor Hallam","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088940536","display_name":"Mark Lupher","orcid":"https://orcid.org/0000-0002-2118-7156","observed_orcids":["https://orcid.org/0000-0002-2118-7156"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark Lupher","raw_affiliation_strings":["Sutro Biopharma, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, South San Francisco, CA","institution_ids":["https://openalex.org/I4210152259"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002590050","https://openalex.org/A5003346545","https://openalex.org/A5011094534","https://openalex.org/A5012211904","https://openalex.org/A5014394545","https://openalex.org/A5015400481","https://openalex.org/A5016532798","https://openalex.org/A5022112792","https://openalex.org/A5027822073","https://openalex.org/A5033160069","https://openalex.org/A5037805629","https://openalex.org/A5045125816","https://openalex.org/A5064566753","https://openalex.org/A5066984672","https://openalex.org/A5068191293","https://openalex.org/A5070704216","https://openalex.org/A5073536299","https://openalex.org/A5073561330","https://openalex.org/A5078931237","https://openalex.org/A5087863988","https://openalex.org/A5088940536","https://openalex.org/A5100637086","https://openalex.org/A5103044490","https://openalex.org/A5103593186","https://openalex.org/A5104018917","https://openalex.org/A5110866577"],"corresponding_institution_ids":["https://openalex.org/I4210152259"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.739,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.84471941,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"128","issue":"22","first_page":"464","last_page":"464"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.12849999964237213,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd74","display_name":"CD74","score":0.9800000190734863},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8999999761581421},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/site-specific-conjugation","display_name":"site-specific conjugation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/ribosome-display","display_name":"ribosome display","score":0.7329999804496765},{"id":"https://openalex.org/keywords/cell-free-protein-synthesis","display_name":"cell-free protein synthesis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/mhc-class-ii","display_name":"MHC class II","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.531238317489624},{"id":"https://openalex.org/C96926380","wikidata":"https://www.wikidata.org/wiki/Q1737968","display_name":"Germinal center","level":4,"score":0.5278444290161133},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4895881116390228},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48949968814849854},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.446583092212677},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.41159164905548096},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4065982699394226},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3477917015552521},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.2624639570713043},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22428548336029053},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.464.464","doi":"https://doi.org/10.1182/blood.v128.22.464.464","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.464.464","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2611382932","https://openalex.org/W2978549124","https://openalex.org/W4315785365","https://openalex.org/W2622081507","https://openalex.org/W4242132448","https://openalex.org/W2741253638","https://openalex.org/W2069832110","https://openalex.org/W2959707089","https://openalex.org/W7096377637","https://openalex.org/W4233680519"],"abstract_inverted_index":{"Abstract":[0],"CD74":[1,22],"is":[2,154,499],"a":[3,76,89],"type":[4],"II":[5,17],"transmembrane":[6],"glycoprotein":[7],"involved":[8],"in":[9,26,134,198,201,210,230,328,402,415,433,475,480,488,496],"the":[10,50,83,159,170,183,329,359,452],"formation":[11],"and":[12,41,71,103,131,174,186,200,212,219,237,314,351,394,449,462,477,492,495,503],"transport":[13],"of":[14,21,44,79,121,164,336,341,366,372,428,486],"MHC":[15],"class":[16],"protein.":[18],"High":[19],"expression":[20],"has":[23],"been":[24],"confirmed":[25],"follicular":[27],"lymphoma,":[28],"diffuse":[29],"large":[30],"B-cell":[31,438,471,482],"lymphoma":[32,39,282,331,362],"(DLBCL),":[33],"chronic":[34],"lymphocytic":[35,38],"leukemia":[36,307],"(CLL)/small":[37],"(SLL)":[40],"other":[42,489,504],"types":[43],"NHL":[45,483],"with":[46,334,391],"immunohistochemistry":[47],"(IHC)":[48],"using":[49,107],"LL1":[51],"antibody":[52,97,118,148,173],"(Stein":[53],"et":[54],"al.":[55],"Clin":[56],"Cancer":[57],"Res":[58],"2007).":[59],"We":[60],"employed":[61],"site-specific":[62],"conjugation":[63,163,189],"technology":[64],"to":[65,88,129,157,177,181],"generate":[66,464],"novel":[67,108,204],"CD74-targeting":[68],"ADCs,":[69],"SP7676":[70,102,185,323,367,461],"SP7675":[72],"(STRO-001)":[73],"that":[74,460],"exhibit":[75],"high":[77],"degree":[78],"homogeneity":[80],"characterized":[81],"by":[82],"drug":[84,208],"linker":[85],"covalently":[86],"binding":[87],"single":[90],"defined":[91],"site.":[92],"The":[93,146],"human":[94],"anti-CD74":[95],"IgG1":[96],"(SP7219)":[98],"used":[99],"for":[100,143,162,215],"ADCs":[101,184,205],"STRO-001":[104,409,432,463,487],"was":[105,175],"engineered":[106],"Fab-based":[109],"ribosome":[110],"display":[111],"methods":[112],"enabling":[113],"selection":[114,126],"from":[115,124,151],"~1012":[116],"different":[117],"variants.":[119],"Hundreds":[120],"unique":[122],"Fabs":[123],"this":[125,152],"were":[127,191],"converted":[128],"IgGs":[130],"expressed":[132],"directly":[133],"Sutro's":[135,166],"proprietary":[136],"cell-free":[137],"protein":[138],"synthesis":[139],"platform,":[140],"Xpress":[141],"CFTM,":[142],"extensive":[144],"screening.":[145],"top":[147,171],"lead":[149,430],"derived":[150],"screen":[153],"further":[155],"tested":[156],"identify":[158],"best":[160],"sites":[161,190],"linker-warheads.":[165],"SP7219":[167],"emerged":[168],"as":[169],"performing":[172],"conjugated":[176],"noncleavable":[178],"DBCO-maytansinoid":[179],"linker-warheads":[180],"form":[182],"STRO-001.":[187],"Since":[188],"selected":[192],"based":[193],"on":[194,446],"highest":[195],"stability":[196],"both":[197],"vitro":[199,223],"vivo,":[202],"these":[203],"lose":[206],"little":[207],"moiety":[209],"circulation":[211],"have":[213],"potential":[214],"improved":[216],"PK,":[217],"safety":[218],"activity":[220,229,468,479],"profiles.":[221],"In":[222,358],"cell":[224,281,284,466,473,490],"proliferation/cytotoxicity":[225],"assays":[226],"show":[227],"potent":[228,465],"1)":[231],"DLBCL":[232],"(germinal":[233],"center":[234],"B-cell-like":[235],"[GCB]":[236],"\"double-hit\")":[238],"lines:":[239,285],"SU-DHL-4,":[240],"IC50":[241,245,250,255,260,265,270,275,287,292,297,310,319],"-":[242,246,251,256,261,266,271,276,288,293,298,300,311,320,442],"1nM;":[243],"SU-DHL-6,":[244],"0.4":[247,262,299],"nM;":[248,253,258,263,268,273,278,290,295,302,313],"WSU-NHL,":[249],"1.6":[252],"Pfeiffer,":[254],".09":[257],"NUDUL-1,":[259],"HT,":[264],"0.7":[267,272],"OCI-LY-19,":[269],"WSU-DLBCL2,":[274],"0.3":[277],"2)":[279],"mantle":[280],"(MCL)":[283],"Mino,":[286],"0.4-0.7":[289],"JVM-2,":[291],"1.7-2.9":[294],"Jeko-1,":[296],"0.6":[301],"3)":[303],"Ph+":[304],"acute":[305],"lymphoblastic":[306],"(ALL):":[308],"SUP-B15,":[309],"3.9-4.6":[312],"4)":[315],"CLL":[316],"(EBV-transformed):":[317],"JVM-13,":[318],"3.0-3.4":[321],"nM.":[322],"elicited":[324],"strong":[325],"anti-tumor":[326,478],"response":[327],"OCI-LY-10":[330],"xenograft":[332,363,493],"model":[333],"100%":[335],"animals":[337],"achieving":[338],"complete":[339],"regression":[340,401],"tumors":[342],"at":[343,370,377,419,440],"3mg/kg":[344],"every":[345,380],"3":[346,356,381,399,424],"days":[347,382],"x":[348,355,383,398,423],"5":[349,384],"doses":[350,445],"10":[352,378,395],"mg/kg":[353,379,396,421,444],"weekly":[354,397,422],"doses.":[357,425],"WSU-DLCL2":[360],"\"double-hit\"":[361],"model,":[364],"administration":[365],"(with":[368],"re-dosing":[369],"time":[371],"re-growth)":[373],"produced":[374],"tumor":[375,387,406,412],"regressions":[376],"(6/8":[385],"mice":[386],"free,":[388],"remaining":[389],"2":[390],"small":[392],"tumors)":[393],"(tumor":[400],"most":[403],"animals,":[404],"4/8":[405],"free).":[407],"Additionally,":[408],"exhibits":[410],"dose-dependent":[411,437],"growth":[413],"inhibition":[414],"SUDHL-6":[416],"xenografts":[417],"starting":[418],"2.5":[420],"Exploratory":[426],"testing":[427],"our":[429],"candidate,":[431],"cynomologous":[434],"monkeys":[435],"showed":[436],"depletion":[439],"1":[441,448],"30":[443],"Day":[447],"15,":[450],"confirming":[451],"intended":[453],"pharmacodynamic":[454],"effect.":[455],"Our":[456],"preliminary":[457],"data":[458],"demonstrate":[459],"killing":[467],"across":[469],"multiple":[470],"lymphoma/leukemia":[472],"lines":[474,491],"vitro,":[476],"preclinical":[481],"xenografts.":[484],"Evaluation":[485],"models":[494],"combination":[497],"studies":[498,506],"ongoing.":[500],"GLP":[501],"toxicology":[502],"IND-enabling":[505],"are":[507],"planned.":[508],"Disclosures":[509],"Li:":[510],"Sutro":[511],"Biopharma:":[512,515,518,521,536,539,542,545,548,551,554,557,560,563,566,569,572,575,578,581,584,587],"Employment.":[513,516,519,522,524,526,528,530,532,534,537,540,543,546,549,552,555,558,561,564,567,570,573,576,579,582,585,588],"Abrahams:Sutro":[514],"Embry:Sutro":[517],"Yu:Sutro":[520],"Kahana:Celgene:":[523],"Brown:Celgene:":[525],"Narla:Celgene:":[527],"Barnes:Celgene:":[529],"Schwartz:Celgene:":[531],"Boylan:Celgene:":[533],"Zawada:Sutro":[535],"Stephenson:Sutro":[538],"Bruhns:Sutro":[541],"Bussell:Sutro":[544],"Steiner:Sutro":[547],"Galan:Sutro":[550],"Kline:Sutro":[553],"Yam:Sutro":[556],"Stafford:Sutro":[559],"Hoffmann:Sutro":[562],"Matheny:Sutro":[565],"DeAlmeida:Sutro":[568],"Vasquez:Sutro":[571],"Heinsohn:Sutro":[574],"Sato:Sutro":[577],"Molina:Sutro":[580],"Hallam:Sutro":[583],"Lupher:Sutro":[586]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2017-05-26T00:00:00"}